DB16363Experimental
PlasmaCord is platelet-poor plasma that is derived by fractionation from sterile umbilical cord and placental blood. It is developed by Cellpraxis and is currently being investigated against severe acute respiratory...
- Also known as
- Human umbilical cord and placental blood plasma
- Code names
- PlasmaCord
What you can answer from here — as of March 06, 2025
Which companies are running trials of PlasmaCord, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account